MCR Trademark

Trademark Overview

On Thursday, April 2, 2020, a trademark application was filed for MCR with the United States Patent and Trademark Office. The USPTO has given the MCR trademark a serial number of 88857515. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 6, 2024. This trademark is owned by Repertoire Immune Medicines, Inc.. The MCR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, pharmaceutical research, medical research; custom development of biochemical reagents and assays; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals
mcr

General Information

Serial Number88857515
Word MarkMCR
Filing DateThursday, April 2, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2021

Trademark Statements

Goods and ServicesScientific research, pharmaceutical research, medical research; custom development of biochemical reagents and assays; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 18, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRepertoire Immune Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRepertoire Immune Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Thursday, April 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 22, 2020ASSIGNED TO EXAMINER
Sunday, June 28, 2020NON-FINAL ACTION WRITTEN
Sunday, June 28, 2020NON-FINAL ACTION E-MAILED
Sunday, June 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 23, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 30, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 20, 2021SOU TEAS EXTENSION RECEIVED
Monday, September 20, 2021SOU EXTENSION 1 FILED
Monday, September 20, 2021SOU EXTENSION 1 GRANTED
Wednesday, September 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 30, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 30, 2022SOU EXTENSION 2 FILED
Wednesday, March 30, 2022SOU EXTENSION 2 GRANTED
Friday, April 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 29, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 29, 2022SOU EXTENSION 3 FILED
Thursday, September 29, 2022SOU EXTENSION 3 GRANTED
Saturday, October 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 30, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 30, 2023SOU EXTENSION 4 FILED
Saturday, April 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, April 8, 2023SOU EXTENSION 4 GRANTED
Tuesday, April 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 13, 2023SOU EXTENSION 5 FILED
Thursday, September 14, 2023SOU EXTENSION 5 GRANTED
Friday, September 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, May 6, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

development research scientific others product field pharmaceuticals biotechnology consultation reagents